| Document |
Document Title |
|
JP2005518329A |
The invention involves a methods and compositions for use in photodynamic therapy. Novel perylenequinone derivatives, conjugates comprising perylenequinone derivatives and a binding agent, and methods of treatment using these composition...
|
|
JP3663229B2 |
PURPOSE: To obtain the subject compound useful as a synthetic intermediate for a sulfamoyl urea herbicide, by reacting a 2-nitrobenzoyl halide compound with magnesium enolate of acetylbutyrolactone. CONSTITUTION: A compound of formula I ...
|
|
JP3650199B2 |
To obtain the subject compound having an excellent antifungal action against the pathogenic fungi of plants. The compound of formula I (Ar is benzophenone residue; R1, R3 are each independently a l-4C alkyl; R2 is a 4-10C aliphatic hydro...
|
|
JP2005511676A |
Substituted arylcycloalkanes, compositions containing them and use thereof. The present invention relates especially to substituted arylcycloalkanes with therapeutic activity, which may be used such as in oncology.
|
|
JP2005507416A |
An improved method of producing keto acids having the formula (I), wherein R1 and R2 independently represent (a) hydrogen, wherein at least one of R1 and R2 do not stand for hydrogen, (b) branched or unbranched alkyl of 1-18 carbon atoms...
|
|
JP3626763B2 |
There is provided o-nitrophenyl cyclopropyl ketone, a key intermediate in the manufacture of the crop-selective, herbicidal agent 1-{[o-(cyclopropylcarbonyl)phenyl]sulfamoyl}-3-(4,6-dimethox
y-2-pyrimi dinyl)urea and a method for the pre...
|
|
JP3626191B2 |
PCT No. PCT/EP94/02981 Sec. 371 Date Apr. 30, 1996 Sec. 102(e) Date Apr. 30, 1996 PCT Filed Sep. 7, 1994 PCT Pub. No. WO95/07885 PCT Pub. Date Mar. 23, 1995Compounds of the formula: wherein R is a hydrogen atom or an OY group; R1 is a hy...
|
|
JP2005504791A |
A process for preparing 4-haloalkylnicotinic esters of the formula (I), where RF is (C1-C4)-haloalkyl and R is (C1-C6)-alkyl; which comprises a) reacting an aminoketone of the formula (II), RF-C(O)-CH-CH-NH2 (II) in a condensation reacti...
|
|
JP2005502654A |
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for t...
|
|
JP2005015436A |
To provide a new method for producing an alkynyl ketone.The method for producing the alkynyl ketone comprises reacting a terminal alkyne with an aromatic iodinated material and carbon monoxide in the presence of a catalyst system contain...
|
|
JP2005500401A |
The invention provides 1,2-substituted cyclic compounds useful for treatment of diseases or disorders arising from abnormal or inappropriate cell proliferation, such as tumour growth, tumour metastasis and associated angiogenesis, as wel...
|
|
JP3595390B2 |
PURPOSE: To obtain the subject compound capable of controlling an absorbing wavelength according to purposes and of giving itself high solubility to organic solvents, also having resistance to light, thus useful for electrophotographic c...
|
|
JP2004534781A |
Arylaminopropane analogues are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more ...
|
|
JP2004323394A |
To widen the width of selectable light absorbing organic compounds by providing a new organic compound to absorb visible lights having a wide wavelength range in preparing a photopolymerizable composition.The cyclopentanone compound has ...
|
|
JP3582337B2 |
|
|
JP2004532209A |
The present invention provides compounds of formula (I), which are antagonists of the 5-HT6 receptor.
|
|
JP2004531493A |
A-(B)n-X (I) A-(B)n-Q (II) Structural Relationship of Example (8) to its Potential Metabolites Numbers in Parentheses denote examples in the specification A compound is of general formula (I) wherein (A) is a moiety comprising one of mor...
|
|
JP2004531474A |
Symmetrically disubstituted aromatic compounds and pharmaceutical compositions containing such compounds that inhibit and/or modulate the activity of poly(ADP-ribose) glycohydrolase, also known as PARG, are described. The invention is al...
|
|
JP2004529911A |
There are disclosed compounds of the formula a prodrug thereof, or a pharmaceutically acceptable salt, solvate or isomer of said compound or of said prodrug, which are useful for the treatment of chemokine-mediated diseases such as acute...
|
|
JP2004269428A |
To provide a method for easily producing a high-purity 1,4-diaminoanthraquinone in high yield.The 1,4-diaminoanthraquinone of formula(2) is obtained by oxidizing a leuko 1,4-diaminoanthraquinone of formula(1) with bromine or aqueous hydr...
|
|
JP2004262788A |
To provide a method for producing a cyclic fluorine-containing enamine compound having a carbonyl group by which the fluorine-containing enamine compound useful as an intermediate for medicines and agrochemicals and a raw material monome...
|
|
JP3564791B2 |
PURPOSE: To obtain α-aminoketone under mild condition in high yield and selectivity by an aminolysis reaction using an α,β-epoxysulfone and a secondary amine. CONSTITUTION: The objective α-aminoketone of formula III is produced by re...
|
|
JP2004250545A |
To provide an organic material which efficiently absorbs two photons, i.e. has a large two-photon absorption cross section.A nonresonant two-photon absorption material contains a compound of formula (1) or (2) (wherein R11-R16 and R21-R2...
|
|
JP3560980B2 |
PCT No. PCT/CH95/00309 Sec. 371 Date Sep. 12, 1997 Sec. 102(e) Date Sep. 12, 1997 PCT Filed Dec. 27, 1995 PCT Pub. No. WO96/21167 PCT Pub. Date Jul. 11, 1996The invention relates to crosslinked polymers, which are polymerisation products...
|
|
JP2004523523A |
The invention relates to a process for carrying out a homogeneously catalyzed C-C coupling reaction between an optionally substituted (hetero)aromatic bromide compound and a second reactant, which is chosen from the group of olefins in w...
|
|
JP3542708B2 |
To simply produce the subject compounds useful as medicines, agrochemicals, perfumes, etc., in high yield, high syn/anti selectivity and high optical yield by reacting a specific aldimine compound with a specified silyl enol ether in the...
|
|
JP3542482B2 |
To obtain a novel compound having excellent inhibition for a specific phosphodiesterase and useful as a therapeutic agent against inflammatory diseases such as asthma, skin inflammation, etc., and multiple sclerosis, etc. This 3-anilino-...
|
|
JP2004520333A |
The present invention relates to a process for preparing (±)-trans-4-p-fluorophenyl-3-hyroxymethyl-1-methylpiperdine
of formula (I). The present invention also relates to novel intermediates of the formula (IX) and (IX') methods for pr...
|
|
JP2004520397A |
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid lev...
|
|
JP2004517903A |
A primary intermediate for use in hair coloring compositions for oxidative dyeing of hair is 4-amino-2-(1-hydroxy-ethyl)-phenol.
|
|
JP2004517946A |
Keratin fiber coloring agents containing (1,1'-biphenyl)-2,4-diamine derivatives of general formula (I) or a physiologically tolerated salt thereof and novel (1,1'-biphenyl)-2,4-diamine derivatives.
|
|
JP3533577B2 |
PURPOSE: To provide the new compounds with a low chlorine content and a low viscosity useful as a reactive diluent, a softening agent and an adhesion enhancer or the like in epoxy resin formulations. CONSTITUTION: These are the compounds...
|
|
JP3531801B2 |
To obtain the novel subject compound having excellent resistance to various treatments by which keratin fibers would be processed, useful as a direct dye capable of attaining strong coloring in a wide range of color tones by bringing the...
|
|
JPWO2002053523A1 |
A tropolone derivative represented by the formula (I) having a retinoid action and useful as an active ingredient of a medicine [R1 to R4 represent a hydrogen atom, an alkyl group, or an alkoxy group; the ring represented by Ar is an ary...
|
|
JP3522754B2 |
|
|
JP3517240B2 |
|
|
JP2004510754A |
A compound of the formula in which R1 and R2 are each hydrogen or C1-4 alkyl, or R1 and R2 together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl or morpholino group, said gr...
|
|
JP2004509070A |
This invention relates to the novel use of dianilino squarates in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
|
|
JP3508984B2 |
To obtain a new compound useful for durable light emission devices capable of high-luminance light output. This new compound is an organic compound of formula I [X is a (substituted) arylene or heterocycle; Ar1 to Ar4 are each a (substit...
|
|
JP3508214B2 |
PURPOSE: To efficiently obtain 1-aminoanthraquinones useful as intermediate for a dye, pigment and pharmaceutical by the rearrangement of N- phenylphthalimide compound in the presence of a super strong acid in a single process. CONSTITUT...
|
|
JP2004507518A |
The present invention relates to a process for the preparation of N-arylanthranilic acids, and a process for the preparation of N-aryl anthranilic esters, amides, and hydroxamic esters.
|
|
JP3503403B2 |
To improve the luminous intensity, luminous efficiency, and stability in repeated use by reacting a dihalide of a specified divalent residue, a secondary amine derivative, potassium carbonate and a catalyst in a solvent. A dihalide of a ...
|
|
JP2004059570A |
To obtain a complex compound having high heat resistance and low crystallinity and excellent in charge transfer properties and provide a charge transfer material comprising the complex compound and a highly functional organic elefctrolum...
|
|
JP2004505888A |
A diverse set of tubulin binding ligands have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for mo...
|
|
JP2004505100A |
A method for the synthesis of an alpha,beta-unsaturated ketone useful for making substituted 1,4-dihydropyridines is described by reacting an aldehyde with pyrrolidine and then adding a ketone followed by trifluoroacetic acid at low temp...
|
|
JP2004043433A |
To provide a new morpholinoketone derivative and its use.The morpholinoketone derivative is represented by the general formula [wherein X1 and X2 are each H, S, N, O or NR (R is an alkyl group) and X1 is X2 when X1 and X2 are not H; R' i...
|
|
JP2004503519A |
A process for the preparation of a compound of formula (I) or a single enantiomer thereof, or a salt or a solvate thereof, wherein W is a chiral auxiliary or hydrogen and P1 and P2 are each independently selected from hydrogen or a prote...
|
|
JP2004502666A |
The invention relates to an oxidative coloring agent for keratin fibers, in particular hair based on a developing agent-coupling agent combination, which contains as a developing agent at least one 2-hydroxy-5-amino-biphenyl derivative o...
|
|
JP2004501885A |
To provide a monomer having excellent ultraviolet absorption efficiency, a wide ultraviolet absorption wavelength range, and good copolymerizability with other comonomer. A propadion derivative represented by the general formula [A]. [Ch...
|
|
JP3487067B2 |
PURPOSE: To extremely easily obtain 3-amino-2-hydroxyacetophenone salt excellent in fluidity with small crystal bulkiness, improved in productivity and operability and useful as an intermediate for medicines by allowing sulfuric acid to ...
|
